| scholarly article | Q13442814 |
| P50 | author | Jens P. Goetze | Q51497843 |
| Olav Wendelboe Nielsen | Q54665439 | ||
| Lars Køber | Q33310611 | ||
| Kasper Iversen | Q41657547 | ||
| P2093 | author name string | Henrik Nielsen | |
| Ingrid Hunter | |||
| Søren Boesgaard | |||
| Morten Bay | |||
| Vibeke Kirk | |||
| Bo K Lauridsen | |||
| P2860 | cites work | Accuracy of N-terminal-pro-atrial natriuretic peptide in patients admitted to emergency department | Q48786011 |
| The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study | Q48935479 | ||
| Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. | Q64900434 | ||
| Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study | Q81241835 | ||
| Measurement of the total proANP product in mammals by processing independent analysis | Q84441379 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). | Q30908639 | ||
| N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). | Q30908647 | ||
| Evaluating the yield of medical tests | Q34277948 | ||
| Plasma natriuretic peptide levels and the risk of cardiovascular events and death | Q34298401 | ||
| NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. | Q35580797 | ||
| The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects | Q37163361 | ||
| Natriuretic peptide testing in clinical medicine | Q37245749 | ||
| Processing-independent analysis of peptide hormones and prohormones in plasma | Q37971589 | ||
| Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events | Q39703968 | ||
| Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. | Q39950925 | ||
| Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. | Q39984342 | ||
| N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults | Q40432735 | ||
| Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery | Q41986199 | ||
| B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study | Q42040074 | ||
| N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification | Q44042488 | ||
| B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction | Q44456354 | ||
| The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. | Q44777037 | ||
| N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population | Q45016727 | ||
| Multiple marker approach to risk stratification in patients with stable coronary artery disease | Q45573743 | ||
| A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model | Q46195716 | ||
| Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study | Q46665471 | ||
| Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department | Q46943201 | ||
| Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death | Q47860327 | ||
| Plasma brain natriuretic peptide in assessment of acute dyspnoea | Q48173487 | ||
| Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. | Q48174219 | ||
| Brain natriuretic peptide in an elderly population | Q48595902 | ||
| The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes | Q48766104 | ||
| P433 | issue | 11 | |
| P921 | main subject | hospitalization | Q3140971 |
| P304 | page(s) | e003288 | |
| P577 | publication date | 2013-11-25 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study | |
| P478 | volume | 3 |
| Q88631854 | B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure |
| Q47747440 | Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study |
| Q40700346 | Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload |
| Q51000313 | Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes. |
| Q45110914 | Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting |
| Q36270396 | Plasma pro-atrial natriuretic peptide to estimate fluid balance during open and robot-assisted esophagectomy: a prospective observational study |
| Q46632631 | Total plasma proANP increases with atrial dilatation in horses |
Search more.